Home
Conditions
Acral Melanoma

Clinical trial condition

Acral Melanoma

Explore clinical trials studying Acral Melanoma. Study availability and eligibility vary by location and protocol.

10 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Acral Melanoma trial results

Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT04119024

Conditions: Acral Melanoma, Adenocarcinoma, Adenocarcinoma of Lung, +59 more
Locations: City of Hope Duarte, California, United States

UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Stanford Cancer Institute Stanford, California, United States

View Trial Details

Recruiting

A Beta-only IL-2 ImmunoTherapY Study

NCT05086692

Conditions: Acral Melanoma, Adenocarcinoma, Adenoma, +120 more
Locations: Sharp Memorial Hospital San Diego, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Providence Saint John's Health Center Santa Monica, California, United States

Boca Raton Regional Hospital Boca Raton, Florida, United States

View all 27 locations

View Trial Details

Recruiting

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

NCT06965231

Conditions: Acral Melanoma, Melanoma, Melanoma of Skin, +12 more
Locations: Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

Cancer center, Shanghai 411 hospital, China RongTong Medical Healthcare Group Co.Ltd./411 Hospital, Shanghai University Shanghai, Shanghai Municipality, China

Department of Surgical Oncology, Fudan University Shanghai Cancer Center Minhang Branch Hospital Shanghai, Shanghai Municipality, China

Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma

NCT05512481

Conditions: Acral Melanoma, Apatinib, Camrelizumab, +15 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma

NCT05789043

Conditions: Acral Melanoma
Locations: Beijing Cancer Hospital Beijing, China

View Trial Details

Recruiting

Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma

NCT04331093

Conditions: Acral Melanoma
Locations: The first hospital of Jilin University Changchun, Jilin, China

View Trial Details

Not Yet Recruiting

Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma

NCT07347444

Conditions: Acral Melanoma, Mucosal Melanoma
Locations: Fudan university cancer hospital Shanghai, China

View Trial Details

Not Yet Recruiting

An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.

NCT06661577

Conditions: Acral Melanoma, Benign Skin Nevus, Benign Skin Tumor, +21 more
Locations: Manukau Super clinic Auckland, New Zealand

Sir Willliam Manchester Plastic surgery suite, Middlemore Hosptial Auckland, New Zealand

View Trial Details

Completed

Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

NCT05628883

Conditions: Acral Melanoma, Conjunctival Melanoma, Cutaneous Melanoma, +23 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma

NCT00788775

Conditions: Acral Melanoma, Melanoma, Mucosal Lentiginous Melanoma, +11 more
Locations: The Angeles Clinic and Research Institute Santa Monica, California, United States

University of Colorado Aurora, Colorado, United States

Moffitt Cancer Center Tampa, Florida, United States

University of Chicago Chicago, Illinois, United States

View Trial Details

Acral Melanoma

Acral Melanoma trial results

Related conditions